Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 2, 2008, Pages 445-450

  Eller, Triin ^a   Vasar, Veiko ^a   Shlik, Jakov ^b   Maron, Eduard ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cytokines; Escitalopram; Interleukin 8; Major depression; Soluble interleukin 2 receptor; Tumor necrosis factor alpha

Indexed keywords

ESCITALOPRAM; INTERLEUKIN 8; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGE FACTORS; CITALOPRAM; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-8; MALE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38749102020     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.09.015     Document Type: Article

References (38)

1. Anisman H., Kokkinidis L., and Merali Z. Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Behav Immun 16 (2002) 544-556
2. Basterzi A., Aydemir C., Kisa C., Aksaray S., Tuzer V., Yazici K., et al. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol Clin Exp 20 (2005) 473-476
3. Bonaccorso S., Puzella A., Marino V., Pasquini M., Biondi M., Artini M., et al. Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Research 105 (2001) 45-55
4. Brambilla F., Monteleone P., and Maj M. Interleukin-1β and tumor necrosis factor-α in children with major depressive disorder or dysthymia. Journal of Affective Disorders 78 (2004) 273-277
5. Brustolim D., Ribeiro-dos-Santos R., Kast R., Altschuler E., and Soares M. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. International Immunopharmacology 6 (2006) 903-907
6. Capuron L., and Miller A. Cytokines and psychopathology: lessons from Interferon-α. Biol Psychiatry 56 (2004) 819-824
7. Capuron L., Neurauter G., Musselman D., Lawson D., Nemeroff C., Fuchs D., et al. Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment. Biol. Psychiatry 54 (2003) 906-914
8. Cyranowski J., Marsland A., Bromberg J., Whiteside T., Chang Y., and Matthews K. Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain, Behaviour, and Immunity 21 (2007) 229-237
9. Diamond M., Kelly J., and Connor T. Antidepressants suppress production of the Th1 cytokine interferon-γ, independent of monoamine transporter blockade. European Neuropsychopharmacology 16 (2006) 481-490
10. Himmerich H., Binder E., Künzel H., Schuld A., Lucae S., Uhr M., et al. Successful antidepressant therapy restores the disturbed interplay between TNF-α system and HPA Axis. Biol Psychiatry 60 (2006) 882-888
11. Kaestner F., Hettich M., Peters M., Sibrowski W., Hetzel G., Ponath G., et al. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. Journal of Affective Disorders 87 (2005) 305-311
12. Kagaya A., Kugaya A., Takebayashi M., Fukue-Saeki M., Saeki T., Yamawaki S., et al. Plasma concentrations of interleukin-1β, interleukin.6, soluble interleukin-2 receptor and tumor necrosis factor α of depressed patients in Japan. Neuropsychobiology 43 (2001) 59-62
13. Kenis G., and Maes M. Effects of antidepressants on the production of cytokines. International Journal of Neuropsychopharmacology 5 (2002) 401-412
14. Kim Y., Na K., Shin K., Jung H., Choi S., and Kim J. Cytokine imbalance in the pathophysiology of major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 31 (2007) 1044-1053
15. Kubera M., Kenis G., Bosmans E., Kajta M., Basta-Kaim A., Scharpe S., et al. Stimulatory effect of antidepressant on the production of IL-6. International Immunopharmacology 4 (2004) 185-192
16. Lanquillon S., Krieg J.-C., Bening-Abu-Shach U., and Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22 (2000) 370-379
17. Lee K., and Kim Y. The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder. International Immunopharmacology 6 (2006) 1298-1304
18. Lin A., Song C., Kenis G., Bosmans E., De Jongh R., Scharpe S., et al. The in vitro immunosuppressive effects of moclobemide in healthy volunteers. Journal of Affective Disorders 58 (2000) 69-74
19. Maes M., Meltzer H., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. Journal of Affective Disorders 18 (1995) 301-309
20. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., and Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9 (1997) 853-858
21. Maes M., Song C., Lin A., Bonaccorso S., Kenis G., DeJongh R., et al. Negative immunoregulatory effects of antidepressants: inhibition of interferon-γ and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20 (1999) 370-379
22. Maes M., Chiavetto L., Bignotti S., Tura B., Pioli R., Boin F., et al. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukaemia inhibitory factor receptor. Schizophrenia Research 54 (2002) 191-281
23. Malek-Ahmadi P., and Ghandour E. Bupropion for treatment of interferon-induced depression. The Annals of Pharmacotherapy 38 (2004) 1202-1205
24. Marques-Deak A., LotufoNeto F., Dominguez W., Solis A., Kurcgant D., Sato F., et al. Cytokine profiles in women with different subtypes of major depressive disorder. Journal of Psychiatric Research (2007)
25. Mikova O., Yakimova R., Bosmans E., Kenis G., and Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. European Neuropsychopharmacology 11 (2001) 203-208
26. Müller N., Riedel M., Ackenheil M., and Schwarz M. Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation. World J Biol Psychiatry 1 (2000) 173-179
27. Myint A., Leonard B., Steinbusch H., and Kim Y. Th1, Th2, and Th3 cytokine alterations in major depression. Journal of Affective Disorders 88 (2005) 167-173
28. Narita K., Murata T., Takahashi T., Kosaka H., Omata N., and Wada Y. Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy. Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 (2006) 1159-1162
29. O'Brien S., Scully P., Scott L., and Dinan T. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. Journal of Affective Disorders 90 (2006) 263-267
30. O'Brien S., Scully P., Fitzgerald P., Scott V., and Dinan T. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. Journal of Psychiatric Research 41 (2007) 326-331
31. Pollak Y., Ovadia H., Orion E., Weidenfeld J., and Yirmiya R. The EAE-associated behavioural syndrome: I. Temporal correlation with inflammatory mediators. Journal of Neuroimmunology 137 (2003) 94-99
32. Roumestan C., Michel A., Bichon F., Portet K., Detoc M., Henriquet C., et al. Anti-inflammatory properties of desipramine and fluoxetine. Respiratory Research 8 (2007) 35
33. Schiepers O., Wichers M., and Maes M. Cytokines in major depression. Progress in Neuro-Psychophatmacology & Biological Psychiatry 29 (2005) 201-217
34. Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, et al., in press.
35. Song C., Lin A., Bonaccorso S., Heide C., Verkerk R., Kenis G., et al. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. Journal of Affective Disorders 49 (1998) 211-219
36. Szuster-Ciesielska A., Tustanowska-Stachura A., Słotwińska M., Marmurowska-Michałowska H., and Kandefer-Szerszeń M. In vitro immunoregulatory effects of antidepressants in healthy volunteers. Polish Journal of Pharmacology 55 (2003) 353-362
37. Tsao C., Lin J., Chen C., Bai C., and Wu S. Cytokines and serotonin transporter in patients with major depression. Progress in Neuro-Psychophatmacology & Biological Psychiatry 30 (2006) 899-905
38. Tuglu C., Kara S., Caliyurt O., Vardar E., and Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 170 (2003) 429-433